ライフサイエンスコーパス: reproductive technology

1 in vitro to produce spermatozoa for assisted reproductive technology.

2 fication is a standard procedure in assisted reproductive technology.

3 time to pregnancy >=12 mo or use of assisted reproductive technology.

4 erage of fertility preservation and assisted reproductive technology.

5 erage of fertility preservation and assisted reproductive technology.

6 ce of anisogamy and for outcomes of assisted reproductive technology.

7 al or decrease the need for complex assisted reproductive technology.

8 y may affect the outcomes of modern assisted reproductive technology.

9 estations resulting from the use of assisted reproductive technology.

10 ns and in outcomes after the use of assisted reproductive technology.

11 c counseling of couples who opt for assisted reproductive technology.

12 ing focus on spermatozoa sorting in assisted reproductive technology.

13 ed to yield important insights into emerging reproductive technologies.

14 lity and infertility, and improving assisted reproductive technologies.

15 food production traits and support advanced reproductive technologies.

16 loped to increase the efficiency of assisted reproductive technologies.

17 raise ethical and social concerns regarding reproductive technologies.

18 ons, with potential applications in assisted reproductive technologies.

19 iations were modified by the use of assisted reproductive technologies.

20 d and could lead to improvements in assisted reproductive technologies.

21 nduction and caesarean delivery and assisted reproductive technologies.

22 idity, and stability to advance the assisted reproductive technologies.

23 hout the world are permitted to use assisted reproductive technologies.

24 during infertility treatments using assisted reproductive technologies.

25 ng multiple embryo transfers during assisted reproductive technologies (0.06), cervical cerclage (0.1

26 .001), and were more likely to use assisted reproductive technology (172 of 692 [24.9%] vs 27 of 158

27 Infants conceived with assisted reproductive technology accounted for 0.6 percent of all

28 The use of assisted reproductive technology accounts for a disproportionate

29 age, BMI, gravidity, parity, use of assisted reproductive technology, adverse obstetric history, or c

30 valence of monozygotic twinning, of assisted reproductive technology among parents, and of disturbanc

31 velopment is a gateway to improving assisted reproductive technologies and stem cell research.

32 ust 23, 2021, using the Society for Assisted Reproductive Technology and BabyCenter, an online media

33 e whether pregnancies conceived via assisted reproductive technology and exposed to Hurricane Katrina

34 conducted a validation study of the assisted reproductive technology and infertility drug use check b

35 in 1996 and 1997 and conceived with assisted reproductive technology and used as a comparison group 3

36 mal imprinting are found in cancer, assisted reproductive technologies, and several human syndromes.

37 and work, gay and lesbian parenting, the new reproductive technologies, and the effect of parental in

38 ery, induction of pregnancy through assisted reproductive technology, and any concurrently ongoing pr

39 d childbearing, infertility, use of assisted reproductive technology, and career alterations to accom

40 f infertility but no treatment with assisted reproductive technology, and pregnancies in women with n

41 cy of more than 12 months or use of assisted reproductive technology; and miscarriage, defined as pre

42 cy of more than 12 months or use of assisted reproductive technology; and miscarriage, defined as pre

43 of this observation for the use of assisted reproductive technologies are especially relevant to con

44 Pregnancies resulting from assisted reproductive technology are associated with an increased

45 Assisted reproductive technologies (ART) are associated with seve

46 Assisted reproductive technologies (ART) are increasingly used, h

47 Clomiphene and assisted reproductive technologies (ART) are methods used to help

48 Assisted reproductive technologies (ART) are not yet systematical

49 is of utmost concern for improving assisted reproductive technologies (ART) because low-fitness sper

50 Assisted reproductive technologies (ART) can address infertility,

51 Embryos generated with the use of assisted reproductive technologies (ART) can develop overgrowth s

52 Children conceived by assisted reproductive technologies (ART) display a level of vascu

53 f children born since the origin of Assisted Reproductive Technologies (ART) exceeds 5 million.

54 A key factor in the use of assisted reproductive technologies (ART) for diverse species is t

55 The use of assisted reproductive technologies (ART) has become increasingly

56 rauterine insemination and in vitro assisted reproductive technologies (ART) procedures performed fro

57 ion breeding programs often rely on assisted reproductive technologies (ART) to produce offspring due

58 Many procedures used in assisted reproductive technologies (ART) to treat human infertili

59 ) is one of the most highly pursued assisted reproductive technologies (ART) worldwide.

60 infertility is often bypassed with assisted reproductive technologies (ART), some accompanied by saf

61 Advances in assisted reproductive technologies (ART), specifically sperm retr

62 hod holds significant potential for assisted reproductive technologies (ART), where metabolic assessm

63 thalate metabolites and outcomes of assisted reproductive technologies (ART).

64 s never smokers (N = 44) undergoing assisted reproductive technologies (ART).

65 s the most widely used technique in assisted reproductive technologies (ART).

66 ty provides significant advances in Assisted Reproductive Technologies (ART).

67 the relatively low success rates of assisted reproductive technologies (ART; ~25%), additives and adj

68 bservations suggests a link between assisted reproductive technology (ART) and epigenetic errors--tha

69 ment has important implications for assisted reproductive technology (ART) and for human embryonic st

70 entage of births are conceived with assisted reproductive technology (ART) and other infertility trea

71 ether pregnancies conceived through assisted reproductive technology (ART) are at an increased risk o

72 hods of gamete manipulation used in assisted reproductive technology (ART) are rapidly proliferating

73 As assisted reproductive technology (ART) becomes increasingly preva

74 the past 25 years, the frequency of assisted reproductive technology (ART) births has increased rapid

75 To examine associations of assisted reproductive technology (ART) conception (vs.

76 rs (median age: 35 y) underwent 437 assisted reproductive technology (ART) cycles for infertility tre

77 dogenously elevated estrogen during assisted reproductive technology (ART) exhibits little adverse ef

78 (AMA, >=35 years) women undergoing assisted reproductive technology (ART) face reduced live birth ra

79 Use of assisted reproductive technology (ART) has been associated with i

80 of children born through the use of assisted reproductive technology (ART) has been increasing.

81 In recent decades, the use of assisted reproductive technology (ART) has increased rapidly.

82 The increasing use of assisted reproductive technology (ART) has raised concerns regard

83 bout the outcomes of pregnancy with assisted reproductive technology (ART) in women with kidney trans

84 Assisted reproductive technology (ART) involves the manipulation

85 The use of assisted reproductive technology (ART) is growing, both to assist

86 Assisted reproductive technology (ART) may affect fetal developme

87 Patients using assisted reproductive technology (ART) may need additional counse

88 in humans and animals suggest that assisted reproductive technology (ART) might affect the epigeneti

89 Assisted reproductive technology (ART) refers to processing gamet

90 failure (IF) in couples undergoing Assisted Reproductive Technology (ART) treatment.

91 natural pregnancies and those after assisted reproductive technology (ART) treatment.

92 Data on live births, assisted reproductive technology (ART) use, and mortality were re

93 igate 1) whether the association of assisted reproductive technology (ART) with preterm birth varies

94 c sperm injection (ICSI), a type of assisted reproductive technology (ART), can induce epimutations a

95 ion (ICSI), the most common type of assisted reproductive technology (ART), might damage the sperm or

96 In assisted reproductive technology (ART), predictive models are bec

97 diabetes, gestational hypertension, assisted reproductive technology (ART), rates of maternal primipa

98 obesity are also more likely to use assisted reproductive technology (ART), which frequently results

99 ion and livebirth among women using assisted reproductive technology (ART).

100 fertility and may begin to turn to assisted reproductive technologies (ARTs) and egg donation.

101 include ovulation stimulation, both assisted reproductive technologies (ARTs) and non-ART ovulation s

102 The association between assisted reproductive technologies (ARTs) and the body mass index

103 Although widely used, assisted reproductive technologies (ARTs) are associated with adv

104 directly from raw semen samples for assisted reproductive technologies (ARTs) as an alternative to de

105 Assisted reproductive technologies (ARTs) have been shown to be a

106 Assisted reproductive technologies (ARTs) have now contributed to

107 During the past two decades, assisted reproductive technologies (ARTs) have revolutionised the

108 The efficiency of assisted reproductive technologies (ARTs) in nonhuman primates is

109 The use of assisted reproductive technologies (ARTs) is steadily increasing

110 sorders in children conceived using assisted reproductive technologies (ARTs), and aberrant DNA methy

111 igh-throughput, would be useful for assisted reproductive technologies (ARTs), as it can allow specif

112 ansfers reported to the Society for Assisted Reproductive Technology between 2014 and 2016.

113 ormonal cycles and the way in which assisted reproductive technologies can be applied, and key differ

114 ctive technology in the Society for Assisted Reproductive Technology Clinic Outcome Reporting System

115 t member clinics of the Society for Assisted Reproductive Technology Clinic Outcomes Report System (S

116 m member clinics of the Society for Assisted Reproductive Technology Clinical Outcomes Reporting Syst

117 ted by linkage with the Society for Assisted Reproductive Technology-Clinical Outcome Reporting Syste

118 state FP mandate status, number of assisted reproductive technology cycles performed, and number of

119 w oocyte yield, and 2 or more prior assisted reproductive technology cycles; reproductive outcomes fo

120 Reproductive technologies designed to uncouple the inher

121 ent (ie, intrauterine insemination, assisted reproductive technology, fertility preservation procedur

122 dications and ethical acceptance of assisted reproductive technologies for adult-onset cancer predisp

123 ation of semen cryopreservation and assisted reproductive technologies for the critically endangered

124 lability of drugs for impotence and advanced reproductive technologies for the treatment of subfertil

125 data collected from the Society for Assisted Reproductive Technology for 33 863 recipients undergoing

126 irst, we established a tractable pipeline of reproductive technologies, from induction of ovulation,

127 on babies conceived globally, using assisted reproductive technologies, fundamental questions remain;

128 tion or later, those conceived with assisted reproductive technology had a risk of low birth weight t

129 though recently an association with assisted reproductive technologies has been described.

130 h weight associated with the use of assisted reproductive technology has been attributed largely to t

131 ew species, beside humans, in which assisted reproductive technology has important clinical applicati

132 ve-birth rates after treatment with assisted reproductive technology have traditionally been reported

133 Assisted reproductive technologies in all mammals are critically

134 eans to improve the success rate of assisted reproductive technologies in fertility clinics.

135 e linked a census of treatment with assisted reproductive technology in South Australia to a registry

136 We linked data from cycles of assisted reproductive technology in the Society for Assisted Repr

137 28], and estrogen [n = 16 948]) and assisted reproductive technology (in vitro fertilization [n = 19

138 states and to understand why use of assisted reproductive technology is not a risk factor for poor bi

139 sus deceased donation, (iii) use of assisted reproductive technologies, (iv) informed consent, (v) cl

140 Advances in reproductive technology may allow men to bypass urologic

141 n infants conceived with the use of assisted reproductive technology may also have a higher risk of l

142 se infertile men conceived using an assisted reproductive technology needs further evaluation.

143 lity, secondary infertility despite assisted reproductive technology, negative self-image, and discom

144 nces in risk factors such as use of assisted reproductive technologies, obesity, smoking, and poor me

145 Developments made in reproductive technology offer women the opportunity to p

146 e following contexts are explored with care: reproductive technologies; organ transplantation; cosmet

147 emen parameters, DNA integrity, and assisted reproductive technology outcomes after varicocele repair

148 are associated with infertility and assisted reproductive technology outcomes is unclear; although, t

149 the safety of contraception, use of assisted reproductive technology, preservation of fertility durin

150 We analyzed data on outcomes of assisted reproductive technology procedures as reported to the Ce

151 monogenic PKD, like other forms of assisted reproductive technology, raises important ethical questi

152 We analyzed national data on assisted reproductive technology reported to the Centers for Dise

153 om the databases of the Society for Assisted Reproductive Technology (SART) in the US and the Human F

154 e findings, captured by Society for Assisted Reproductive Technology (SART) national data, underscore

155 based model produced by Society for Assisted Reproductive Technology (SART).

156 n women who received treatment with assisted reproductive technology, spontaneous pregnancies (i.e.,

157 f infertility have been overcome by assisted reproductive technologies such as in vitro fertilization

158 sence of sperm fertilising ability, assisted reproductive technologies, such as in-vitro fertilisatio

159 cycles reported to the US National Assisted Reproductive Technology Surveillance System during 1996-

160 Assisted reproductive technologies techniques are important and f

161 Preimplantation genetic testing (PGT) is a reproductive technology that selects embryos without (fa

162 The development of efficient reproductive technologies to conserve and regenerate chi

163 is a significant health problem and assisted reproductive technologies to treat infertility.

164 rofiled 25 healthy women undergoing assisted reproductive technology to monitor transcriptional chang

165 f low birth weight after the use of assisted reproductive technology to the rate in the general popul

166 Four physicians from two assisted reproductive technology treatment centers in the United

167 Furthermore, in this era of assisted reproductive technologies, understanding the signalling

168 Assisted reproductive technology use does not appear to be signif

169 Assisted reproductive technology use was previously validated by

170 ltiple pregnancy, placenta praevia, assisted reproductive technology use, macrosomia with a birthweig

171 ancies occurred spontaneously, with assisted reproductive technologies used in the remaining cases.

172 tilization (IVF) is the most common assisted reproductive technology used to treat infertility.

173 vitro gametogenesis to be used for assisted reproductive technologies using NWR iPSCs.

174 evaluate trends in infertility and assisted reproductive technology utilization rates, including pat

175 Assisted reproductive technology was associated with a lower risk

176 The use of assisted reproductive technology was associated with an increased

177 Use of assisted reproductive technology was associated with decreased fe

178 Assisted reproductive technology was associated with increased ri

179 Use of assisted reproductive technology was compared between male and fe

180 cundity can be achieved by means of assisted reproductive technology when there are favorable patient

181 els of CCNA2 in patients undergoing assisted reproductive technology who had successful pregnancies.

182 re common among children born after assisted reproductive technology with fresh embryo transfer (fres

183 500 g) among infants conceived with assisted reproductive technology with the rates in the general po

184 remains a significant challenge for assisted reproductive technology, with implantation failure occur

185 ity causes, childbearing decisions, assisted reproductive technology, workplace support, and reflecti